MEDLINE Journals

    Development of validated stability-indicating assay methods--critical review.


    Bakshi M, Singh S 


    J Pharm Biomed Anal 2002 Jun 15; 28(6) :1011-40.


    This write-up provides a review on the development of validated stability-indicating assay methods (SIAMs) for drug substances and products. The shortcomings of reported methods with respect to regulatory requirements are highlighted. A systematic approach for the development of stability-indicating methods is discussed. Critical issues related to development of SIAMs, such as separation of all degradation products, establishment of mass balance, stress testing of formulations, development of SIAMs for combination products, etc. are also addressed. The applicability of pharmacopoeial methods for the analysis of stability samples is discussed. The requirements of SIAMs for stability study of biotechnological substances and products are also touched upon.


    Chemistry, Pharmaceutical
    Chromatography, High Pressure Liquid
    Computer Simulation
    Drug Contamination
    Drug Stability
    Pharmaceutical Preparations
    Reproducibility of Results
    Technology, Pharmaceutical



    Pub Type(s)

    Journal Article Review

    PubMed ID


    Content Manager
    Related Content

    Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.

    Development and validation of a stability indicating LC method for the assay and related substances determination of exemestane, an aromatase inhibitor.

    A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance.

    A validated stability indicating ion-pair RP-LC method for zoledronic acid.

    A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.

    Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances.

    A validated stability-indicating gas chromatography method for determination of divalproex sodium impurities in pharmaceutical preparation.

    Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.